VeriMom¿Debo evitar hydroxycortisone succinate durante el embarazo? | VeriMom
EU/ECHA substance information shows harmonised classification for reproductive toxicity (Repr. 1A H360 and Repr.2 H361) for hydrocortisone 21‑hemisuccinate (CAS 2203-97-6), so this meets the criterion for confirmed reproductive hazard (h=3). The mechanism is glucocorticoid action with demonstrated ability of systemic corticosteroids to affect fetal development/placenta (m=2). For typical topical cosmetic use, systemic absorption is low (e=1), so exposure from normal topical cosmetic use is expected to be low but not zero. (Sources: ECHA brief profile / C&L inventory; guidance on topical corticosteroids in pregnancy).
ECHA regulatory hazard statements
- •H360
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es hydroxycortisone succinate seguro durante el embarazo?
- EU/ECHA substance information shows harmonised classification for reproductive toxicity (Repr. 1A H360 and Repr.2 H361) for hydrocortisone 21‑hemisuccinate (CAS 2203-97-6), so this meets the criterion for confirmed reproductive hazard (h=3). The mechanism is glucocorticoid action with demonstrated ability of systemic corticosteroids to affect fetal development/placenta (m=2). For typical topical cosmetic use, systemic absorption is low (e=1), so exposure from normal topical cosmetic use is expected to be low but not zero. (Sources: ECHA brief profile / C&L inventory; guidance on topical corticosteroids in pregnancy).
- ¿Es hydroxycortisone succinate seguro durante la lactancia?
- Because of the harmonised reproductive classification for the substance (see ECHA) and the known systemic effects of hydrocortisone, a conservative approach assigns h=3 for lactation context as well. Mechanistically, corticosteroids can distribute systemically and small amounts can appear in milk (m=2). For topical cosmetic application (not systemic therapy), milk exposure is generally low unless applied directly to the breast/nipple (e=1). (Sources: ECHA C&L brief profile; LactMed and NHS topical corticosteroid guidance).
- ¿Es hydroxycortisone succinate seguro para la piel del bebé?
- Harmonised classification (ECHA) indicates reproductive hazard (h=3) for the substance; that harmonised CMR classification applies as the primary hazard signal. Mechanism remains hydrocortisone (glucocorticoid) activity (m=2). Dermal exposure and systemic uptake from baby skin are higher than adult per surface‑area‑to‑weight and immature barrier — therefore exposure score is increased by +1 versus adult topical use (adult e=1 → infant e=2). There is no infant‑specific innocuousness data for cosmetic use of this specific derivative. (Sources: ECHA brief profile; EDF/dermatology and guideline reviews on topical corticosteroids/pregnancy and child skin).
- ¿Cómo puntúa VeriMom a hydroxycortisone succinate?
- VeriMom puntúa hydroxycortisone succinate en 20/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hydroxycortisone succinate en el embarazo?
- Consulta nuestra lista de alternativas seguras a hydroxycortisone succinate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.